Bone mineral disorders in pediatric and adolescent renal transplant recipients

被引:7
|
作者
Derakhshan, Ali [2 ]
Behbahan, Afshin G. [1 ]
Lotfi, Mehrzad [3 ]
Omrani, Gholam-Hossein [4 ]
Fallahzadeh, Mohammad-Hossein [2 ]
Basiratnia, Mitra [2 ]
Al-Hashemi, Ghamar H.
机构
[1] Tabriz Univ Med Sci, Pediat Hlth Res Ctr, Tabriz, Iran
[2] Shiraz Univ Med Sci, Nephrourol Res Ctr, Dept Pediat Nephrol, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dept Radiol, Shiraz, Iran
[4] Shiraz Univ Med Sci, Endocrinol & Metab Res Ctr, Dept Internal Med Endocrinol, Shiraz, Iran
关键词
paediatrics; adolescent; bone densitometry; pediatric renal transplantation; renal osteodystrophy; bone mineral; CHRONIC KIDNEY-DISEASE; DENSITY; CHILDREN; HYPERPARATHYROIDISM; METABOLISM; FGF-23; MASS;
D O I
10.1111/j.1399-3046.2011.01492.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Incomplete resolution of abnormalities of mineral metabolism associated with CRF results in the relatively high prevalence of ROD in pediatric kidney recipients. This non-randomized, cross-sectional, and analytic-descriptive study on bone density, vitamin D, and mineral metabolism was performed in 57 children and adolescents who had received a total of 60 renal allografts in Shiraz, Iran. The height and weight of the patients were measured; their serum calcium (Ca), phosphorus (P), Alk-P, PTH, 25(OH)-vitamin D-3,D- BUN, creatinine, and electrolyte levels were analyzed, and a complete blood count was performed. In addition, standard radiologic bone assessments, which included conventional left hand-wrist radiography and bone mineral densitometry by the DXA technique, were carried out. Special pediatric software was used for age-related interpretation of the Z-scores of BMD. SPSS (R) software (version 15) was used for statistical analyses. We studied 57 patients (27 males [47.4%]) with a mean age of 18.7 +/- 4.25 (9-27) yr and a mean age at transplantation of 13.1 +/- 3.46 (4.5-20) yr. They had a post-transplantation follow-up of 67.1 +/- 33.8 (6-132) months, and all had well-functioning allografts at enrollment. The mean height age of the patients was 11.9 +/- 1.8 (6-15.5), and the mean bone age was 15.6 +/- 3.3 (7-19) yr, which corresponded to mean height-age and bone-age retardations of 5.7 +/- 2.3 (0.5-10.5) and 1.22 +/- 1.47 (0-7) yr, respectively. Hyperphosphatemia and hypercalcemia were each found in nine patients (15.8%), hypophosphatemia in five (8.8%), and hypocalcemia in none of the patients. Seven out of 57 patients (12.3%) had a (CaxP) product of more than 55 mg2/dL2. Hyperparathyroidism was found in 27 (47.3%) and vitamin D-3 deficiency in four (7%) of the cases. The serum level of Alk-P was higher than the age-related normal range in 20 patients (35%). Left hand-wrist radiography showed no radiologic sign of ROD in any patient. The mean BMD Z-score was -1.77 +/- 1.13 (-4.2-1.1) for the lumbar spine and -1.64 +/- 0.89 (-3.9 to 1.9) for the femoral neck. "Stepwise backward regression" revealed a significant inverse correlation between the serum level of PTH and the GFR of the transplanted kidney; this correlation was independent from the influence of other variables such as Ca, P, and Alk-P (p = 0.011, beta = -1.556). Bone age and height age both showed significant correlations with age at transplantation and serum levels of P (p < 0.001), but only bone age had a meaningful correlation with Alk-P (p = 0.036). The BMD Z-scores showed statistically meaningful correlations with the serum level of Alk-P, which were independent from the influence of other variables such as Ca, P, and PTH (p < 0.002). Our study revealed a relatively high prevalence of bone mineral disorder in pediatric kidney recipients, which suggests the need for a routine program for periodic screening of these patients to facilitate early diagnosis of either persistent or evolving manifestations of disturbed mineral metabolism, especially ROD.
引用
收藏
页码:367 / 375
页数:9
相关论文
共 50 条
  • [1] Management of mineral and bone disorders in renal transplant recipients
    Damasiewicz, Matthew J.
    Ebeling, Peter R.
    NEPHROLOGY, 2017, 22 : 65 - 69
  • [2] Bone and Mineral Metabolism Disorders In Pediatric Renal Allograft Recipients
    Kavaz, Asli
    Ozcakar, Z. Birsin
    Ozturk, Burcu Bulum
    Doganay, Beyza
    Ekim, Mesiha
    Yalcinkaya, F. Fatos
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1812 - 1813
  • [3] Bone mineral density in pediatric transplant recipients
    Daniels, MW
    Wilson, DM
    Paguntalan, HG
    Hoffman, AR
    Bachrach, LK
    TRANSPLANTATION, 2003, 76 (04) : 673 - 678
  • [4] BONE MINERAL DENSITY AND VITAMIN D STATUS OF PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Comak, Elif
    Dogan, Cagla Serpil
    Gokceoglu, Arife Uslu
    Akbas, Halide
    Aydin, Funda
    Koyun, Mustafa
    Akman, Sema
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1820 - 1821
  • [5] Bone mineral density in pediatric and adolescent renal transplant patients:: How to evaluate
    Göksen, D
    Darcan, S
    Kara, P
    Mir, S
    Çoker, M
    Kabasakal, C
    PEDIATRIC TRANSPLANTATION, 2005, 9 (04) : 464 - 469
  • [6] Bone loss in pediatric renal transplant recipients
    El-Husseini, AA
    El-Agroudy, AE
    Sobh, MA
    Ghoneim, MA
    NEFROLOGIA, 2003, 23 : 131 - 134
  • [7] Bone mineral density in pediatric liver transplant recipients
    D'Antiga, L
    Zancan, L
    TRANSPLANTATION, 2005, 80 (08) : 1135 - 1136
  • [8] Current Status of Mineral and Bone Disorders in Transplant Recipients
    Elder, Grahame J.
    TRANSPLANTATION, 2023, 107 (10) : 2107 - 2119
  • [9] Mineral and Bone Disorders In Pediatric Chronic Kidney Disease Patients and Renal Allograft Recipients
    Kavaz, Asli
    Ozcakar, Z. Birsin
    Bulum, Burcu
    Ekim, Mesiha
    Yalcinkaya, Fatos
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1495 - 1495
  • [10] BONE MINERAL DISORDERS IN PEDIATRIC RENAL TRANSPLANTION
    Derakhshan, Ali
    Golab, Afshin Ghaleh
    Fallahzadeh, Mohammad-Hossein
    Basiratnia, Mitra
    Lotfi, Mehrzad
    Al-Hashemi, Ghamar Hossini
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 79 - 79